These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
64 related articles for article (PubMed ID: 27266084)
1. [Urinary podocyte and urinary podocalyxin; markers for diabetic nephropathy]. Takemoto M; Shoji M; Yokote K Nihon Rinsho; 2016 Apr; 74 Suppl 2():181-5. PubMed ID: 27266084 [No Abstract] [Full Text] [Related]
2. Urinary podocalyxin is an early marker for podocyte injury in patients with diabetes: establishment of a highly sensitive ELISA to detect urinary podocalyxin. Hara M; Yamagata K; Tomino Y; Saito A; Hirayama Y; Ogasawara S; Kurosawa H; Sekine S; Yan K Diabetologia; 2012 Nov; 55(11):2913-9. PubMed ID: 22854890 [TBL] [Abstract][Full Text] [Related]
3. Urine markers of podocyte dysfunction: a review of podocalyxin and nephrin in selected glomerular diseases. Akankwasa G; Jianhua L; Guixue C; Changjuan A; Xiaosong Q Biomark Med; 2018 Aug; 12(8):927-935. PubMed ID: 29976076 [TBL] [Abstract][Full Text] [Related]
4. Urinary podocalyxin levels were associated with urinary albumin levels among patients with diabetes. Shoji M; Kobayashi K; Takemoto M; Sato Y; Yokote K Biomarkers; 2016; 21(2):164-7. PubMed ID: 26635084 [TBL] [Abstract][Full Text] [Related]
5. [Research on the Combined Detection of Urine UmAlb and Urinary Nephrin, Podocalyxin in Podocyte of MKR Mice with Diabetic Nephropathy]. Zeng J; Zhang X; Yu R; Tang Y; Luo WJ; Chen C; Wu YJ Sichuan Da Xue Xue Bao Yi Xue Ban; 2015 Sep; 46(5):722-5. PubMed ID: 26619543 [TBL] [Abstract][Full Text] [Related]
6. Urinary podocalyxin, the novel biomarker for detecting early renal change in obesity. Suwanpen C; Nouanthong P; Jaruvongvanich V; Pongpirul K; Pongpirul WA; Leelahavanichkul A; Kanjanabuch T J Nephrol; 2016 Feb; 29(1):37-44. PubMed ID: 25905599 [TBL] [Abstract][Full Text] [Related]
7. Urinary podocalyxin positive-element occurs in the early stage of diabetic nephropathy and is correlated with a clinical diagnosis of diabetic nephropathy. Ye H; Bai X; Gao H; Li L; Wu C; Sun X; Zhang C; Shen Y; Zhang J; Lu Z J Diabetes Complications; 2014; 28(1):96-100. PubMed ID: 24075693 [TBL] [Abstract][Full Text] [Related]
8. Urinary podocalyxin as a possible novel marker of intrauterine nephrogenesis and extrauterine podocyte injury. Hayashi T; Tokuriki S; Okuno T; Ohta G; Igarashi A; Ohshima Y Pediatr Nephrol; 2017 Oct; 32(10):1891-1896. PubMed ID: 28439668 [TBL] [Abstract][Full Text] [Related]
9. Podocyte membrane vesicles in urine originate from tip vesiculation of podocyte microvilli. Hara M; Yanagihara T; Hirayama Y; Ogasawara S; Kurosawa H; Sekine S; Kihara I Hum Pathol; 2010 Sep; 41(9):1265-75. PubMed ID: 20447677 [TBL] [Abstract][Full Text] [Related]
10. Increased Urinary Excretion of Podocyte Markers in Normoalbuminuric Patients with Diabetes. Lioudaki E; Stylianou KG; Petrakis I; Kokologiannakis G; Passam A; Mikhailidis DP; Daphnis EK; Ganotakis ES Nephron; 2015; 131(1):34-42. PubMed ID: 26340089 [TBL] [Abstract][Full Text] [Related]
11. [Connective tissue growth factor mediates high glucose-induced down-regulation of podocalyxin expression in mouse podocytes]. Zhang J; Li PH; Yang L; DU QS; Guo TT; Tang X Nan Fang Yi Ke Da Xue Xue Bao; 2011 May; 31(5):839-43. PubMed ID: 21602138 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of renal clinicopathological changes in IgA nephropathy by urinary podocytes excretion and podocalyxin expression. Jiang WL; Peng YM; Liu YH; Liu H; Chen GC; Xu XQ; Zhu XJ; Liu FY Ren Fail; 2012; 34(7):821-6. PubMed ID: 22679920 [TBL] [Abstract][Full Text] [Related]
13. Messenger RNA expression of podocyte-associated molecules in the urinary sediment of patients with diabetic nephropathy. Wang G; Lai FM; Lai KB; Chow KM; Li KT; Szeto CC Nephron Clin Pract; 2007; 106(4):c169-79. PubMed ID: 17596726 [TBL] [Abstract][Full Text] [Related]
14. Long term follow up of biomarkers of podocyte damage and renal function in patients with and without preeclampsia. Palacios de Franco Y; Velazquez K; Segovia N; Sandoval G; Gauto E; Franco Palacios YV; Franco Palacios CR J Bras Nefrol; 2018; 40(4):339-343. PubMed ID: 29782634 [TBL] [Abstract][Full Text] [Related]
15. Biomarkers of glomerular dysfunction in pre-eclampsia - A systematic review. Kerley RN; McCarthy C Pregnancy Hypertens; 2018 Oct; 14():265-272. PubMed ID: 29567337 [TBL] [Abstract][Full Text] [Related]
16. Selective phosphodiesterase-5 (PDE-5) inhibitor vardenafil ameliorates renal damage in type 1 diabetic rats by restoring cyclic 3',5' guanosine monophosphate (cGMP) level in podocytes. Fang L; Radovits T; Szabó G; Mózes MM; Rosivall L; Kökény G Nephrol Dial Transplant; 2013 Jul; 28(7):1751-61. PubMed ID: 23203993 [TBL] [Abstract][Full Text] [Related]
17. Correlations of podocyte injury with glucose regulated protein 78 expression and proteinuria in patients with diabetic nephropathy. Liu YJ; Wen YB; Tao JL; Li JH; Su Y; Ye W; Li H; Li XM; Li XW Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2012 Aug; 34(4):359-63. PubMed ID: 22954118 [TBL] [Abstract][Full Text] [Related]
18. Mesenchymal stem cells ameliorate podocyte injury and proteinuria in a type 1 diabetic nephropathy rat model. Wang S; Li Y; Zhao J; Zhang J; Huang Y Biol Blood Marrow Transplant; 2013 Apr; 19(4):538-46. PubMed ID: 23295166 [TBL] [Abstract][Full Text] [Related]
19. Glucose-induced reactive oxygen species cause apoptosis of podocytes and podocyte depletion at the onset of diabetic nephropathy. Susztak K; Raff AC; Schiffer M; Böttinger EP Diabetes; 2006 Jan; 55(1):225-33. PubMed ID: 16380497 [TBL] [Abstract][Full Text] [Related]
20. Research into the glomerular podocyte--is it relevant to diabetic nephropathy? White KE Diabet Med; 2006 Jul; 23(7):715-9. PubMed ID: 16842474 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]